Beijing HyperStrong Technology Co., Ltd. (SHA:688411)
208.50
-8.81 (-4.05%)
At close: Jul 13, 2026
SHA:688411 Revenue
Beijing HyperStrong Technology had revenue of 2.37B CNY in the quarter ending March 31, 2026, with 53.06% growth. This brings the company's revenue in the last twelve months to 12.43B, up 46.79% year-over-year. In the year 2025, Beijing HyperStrong Technology had annual revenue of 11.61B with 40.42% growth.
Revenue (ttm)
12.43B
Revenue Growth
+46.79%
P/S Ratio
3.19
Revenue / Employee
8.77M
Employees
1,418
Market Cap
39.65B
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 11.61B | 3.34B | 40.42% |
| Dec 31, 2024 | 8.27B | 1.29B | 18.44% |
| Dec 31, 2023 | 6.98B | 4.36B | 165.89% |
| Dec 31, 2022 | 2.63B | 1.79B | 213.40% |
| Dec 31, 2021 | 837.86M | 467.54M | 126.25% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Kingfa Sci. & Tech. | 65.32B |
| Shanghai Electric Power | 41.34B |
| Sailun Group | 37.84B |
| Beijing Jingneng Power | 35.65B |
| Smartsens Technology (Shanghai) | 9.39B |
| Soochow Securities | 8.79B |
| Caitong Securities | 7.48B |
| Gan & Lee Pharmaceuticals. | 3.95B |